Chimeric antigen receptor (CAR) T cell therapy shows clinical activity in patients with aggressive brain tumors
A pioneering Phase I CAR T cell therapy trial for the treatment of glioblastoma at City of Hope demonstrates promising clinical activity against incurable brain tumors, according to research published in Nature Medicine.
Mar 7, 2024
0
16